Quarter 2026/Q2
| Line item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 ANNUAL | 2025 Q3 |
|---|---|---|---|---|---|
| Net Cash Flow from Continuing Investing Activities | -$4.85M | -$1.37M | -$1.50M | -$8.77M | -$2.89M |
| Net Investment Purchase and Sale | $0.00 | $745,000.00 | -$9,000.00 | -$281,000.00 | -$120,000.00 |
| Net PPE Purchase and Sale | -$4.85M | -$2.11M | -$1.49M | -$8.49M | -$2.77M |
| -Change In Other Working Capital | $6.63M | $2.61M | -$856,000.00 | -$2.10M | -$115,000.00 |
| -Change in Other Current Liabilities | -$733,000.00 | -$594,000.00 | $4.87M | $3.94M | -$675,000.00 |
| -Change in Other Current Assets | $310,000.00 | $189,000.00 | $309,000.00 | $1.41M | $144,000.00 |
| Operating Cash Flow | $20.73M | $9.68M | $17.52M | $21.33M | $5.22M |
| Net cash flow from continuing operations | $20.73M | $9.68M | $17.52M | $21.33M | $5.22M |
| Net Income from Continuing Operations | -$1.34M | $645,000.00 | -$4.91M | -$23.47M | -$6.87M |
| Gain/Loss from Continuing Operations | $23,000.00 | $24,000.00 | -$30,000.00 | $160,000.00 | $92,000.00 |
| -Change in Payables and Accrued Expense | $4.77M | -$4.14M | $4.42M | $12.22M | $1.19M |
| Depreciation & Depletion & Amortization | $3.34M | $3.37M | $3.86M | $14.26M | $3.31M |
| Deferred Tax | $12,000.00 | -$3,000.00 | $58,000.00 | $159,000.00 | $78,000.00 |
| Other Non-Cash Items | -$550,000.00 | $64,000.00 | -$62,000.00 | $925,000.00 | $1.58M |
| Change in Working Capital | $7.63M | -$6.02M | $11.81M | $1.06M | -$2.72M |
| -Change in Receivables | $1.30M | $2.74M | -$1.52M | -$14.70M | -$4.64M |
| -Change in Inventory | -$4.32M | $1.34M | $6.05M | -$4.15M | -$3.25M |
| -Change in Prepaid Assets | -$331,000.00 | -$8.17M | -$1.47M | $4.45M | $4.63M |
| Net Cash Flow from Continuing Financing Activities | -$18.27M | $191.24M | $1.59M | $20.11M | $33,000.00 |
| Financing Cash Flow | -$18.27M | $191.24M | $1.59M | $20.11M | $33,000.00 |
| Free Cash Flow | $15.88M | $7.57M | $15.93M | $12.30M | $2.45M |
| Effect of Exchange Rate Changes | -$68,000.00 | -$38,000.00 | -$14,000.00 | $264,000.00 | -$9,000.00 |
| Beginning Cash Balance | $298.53M | $99.02M | $81.43M | $66.09M | $79.07M |
| Net cash flow from investing | -$4.85M | -$1.37M | -$1.50M | -$8.77M | -$2.89M |
| Net Change in Cash | -$2.38M | $199.55M | $17.61M | $32.67M | $2.36M |
| Ending Cash Balance | $296.08M | $298.53M | $99.02M | $99.02M | $81.43M |
| Net Other Financing Charges | -$919,000.00 | -$190,000.00 | -$4,000.00 | -$3.07M | -$1,000.00 |
| Proceeds from Stock Option Exercised | $1.74M | $150,000.00 | $1.60M | $3.18M | $34,000.00 |
| Net Issuance Payments Of Debt | -$20.00M | $0.00 | $0.00 | $20.00M | $0.00 |
| Net Common Stock Issuance | $919,000.00 | $191.28M | – | – | – |
No comments yet — be the first to weigh in on LASR.